Trials / Completed
CompletedNCT02822508
A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 434 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI801 Laxative | BLI801 oral laxative |
| DRUG | BLI801 Placebo | BLI801 oral laxative placebo |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-04-01
- Completion
- 2017-04-01
- First posted
- 2016-07-04
- Last updated
- 2023-11-07
- Results posted
- 2023-11-07
Locations
73 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02822508. Inclusion in this directory is not an endorsement.